Sea anemone toxins as templates for the design of immunosuppressant drugs
Identifieur interne : 005F12 ( PascalFrancis/Checkpoint ); précédent : 005F11; suivant : 005F13Sea anemone toxins as templates for the design of immunosuppressant drugs
Auteurs : W. R. Kem [États-Unis] ; M. W. Pennington [États-Unis] ; R. S. Norton [Australie]Source :
- Perspectives in drug discovery and design [ 0928-2866 ] ; 1999.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:99-0408262Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Sea anemone toxins as templates for the design of immunosuppressant drugs</title>
<author><name sortKey="Kem, W R" sort="Kem, W R" uniqKey="Kem W" first="W. R." last="Kem">W. R. Kem</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Pharmacology and Therapeutics, University of Florida College of Medicine</s1>
<s2>Gainesville, FL 32610-026</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Gainesville, FL 32610-026</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pennington, M W" sort="Pennington, M W" uniqKey="Pennington M" first="M. W." last="Pennington">M. W. Pennington</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Bachem Bioscience Inc., 3700 Horizon Drive</s1>
<s2>King of Prussia, PA 19406</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>King of Prussia, PA 19406</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Norton, R S" sort="Norton, R S" uniqKey="Norton R" first="R. S." last="Norton">R. S. Norton</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Biomolecular Research Institute, 343 Royal Parade</s1>
<s2>Parkville, VIC 3052</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Parkville, VIC 3052</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0408262</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0408262 INIST</idno>
<idno type="RBID">Pascal:99-0408262</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">006285</idno>
<idno type="wicri:Area/PascalFrancis/Curation">006D69</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">005F12</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">005F12</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Sea anemone toxins as templates for the design of immunosuppressant drugs</title>
<author><name sortKey="Kem, W R" sort="Kem, W R" uniqKey="Kem W" first="W. R." last="Kem">W. R. Kem</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Pharmacology and Therapeutics, University of Florida College of Medicine</s1>
<s2>Gainesville, FL 32610-026</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Gainesville, FL 32610-026</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pennington, M W" sort="Pennington, M W" uniqKey="Pennington M" first="M. W." last="Pennington">M. W. Pennington</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Bachem Bioscience Inc., 3700 Horizon Drive</s1>
<s2>King of Prussia, PA 19406</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>King of Prussia, PA 19406</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Norton, R S" sort="Norton, R S" uniqKey="Norton R" first="R. S." last="Norton">R. S. Norton</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Biomolecular Research Institute, 343 Royal Parade</s1>
<s2>Parkville, VIC 3052</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Parkville, VIC 3052</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Perspectives in drug discovery and design</title>
<title level="j" type="abbreviated">Perspect. drug discov. des.</title>
<idno type="ISSN">0928-2866</idno>
<imprint><date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Perspectives in drug discovery and design</title>
<title level="j" type="abbreviated">Perspect. drug discov. des.</title>
<idno type="ISSN">0928-2866</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Activation</term>
<term>Autoimmune disease</term>
<term>Biological activity</term>
<term>Immunosuppressive agent</term>
<term>Ionic channel</term>
<term>Molecular interaction</term>
<term>Peptides</term>
<term>Potassium Cations</term>
<term>Review</term>
<term>Structural analysis</term>
<term>T-Lymphocyte</term>
<term>Three dimensional structure</term>
<term>Toxin</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Toxine</term>
<term>Peptide</term>
<term>Canal ionique</term>
<term>Potassium Cation</term>
<term>Lymphocyte T</term>
<term>Immunodépresseur</term>
<term>Interaction moléculaire</term>
<term>Maladie autoimmune</term>
<term>Activité biologique</term>
<term>Article synthèse</term>
<term>Activation</term>
<term>Analyse structurale</term>
<term>Structure 3 dimensions</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0928-2866</s0>
</fA01>
<fA03 i2="1"><s0>Perspect. drug discov. des.</s0>
</fA03>
<fA05><s2>15-16</s2>
</fA05>
<fA08 i1="01" i2="1" l="ENG"><s1>Sea anemone toxins as templates for the design of immunosuppressant drugs</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Animal Toxins and Potassium Channels</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>KEM (W. R.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>PENNINGTON (M. W.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>NORTON (R. S.)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>DARBON (Hervé)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>SABATIER (Jean-Marc)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Department of Pharmacology and Therapeutics, University of Florida College of Medicine</s1>
<s2>Gainesville, FL 32610-026</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Bachem Bioscience Inc., 3700 Horizon Drive</s1>
<s2>King of Prussia, PA 19406</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Biomolecular Research Institute, 343 Royal Parade</s1>
<s2>Parkville, VIC 3052</s2>
<s3>AUS</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Architecture et Fonction des Macromolécules Biologiques (AFMB), Centre National de la Recherche Scientifique, UPR 9039, IFR 1, 31 Chemin Joseph Aiguier</s1>
<s2>13402 Marseille</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Laboratoire de Biochimie, Faculté de Médecine Nord</s1>
<s2>13916 Marseille</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA20><s1>111-129</s1>
</fA20>
<fA21><s1>1999</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>21308S</s2>
<s5>354000085546110070</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1999 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>53 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>99-0408262</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Perspectives in drug discovery and design</s0>
</fA64>
<fA66 i1="01"><s0>NLD</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02Q</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Toxine</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Toxin</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Toxina</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Peptide</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Peptides</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Péptido</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Canal ionique</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Ionic channel</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Canal iónico</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Potassium Cation</s0>
<s2>NC</s2>
<s2>FR</s2>
<s2>NA</s2>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Potassium Cations</s0>
<s2>NC</s2>
<s2>FR</s2>
<s2>NA</s2>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Potasio Cation</s0>
<s2>NC</s2>
<s2>FR</s2>
<s2>NA</s2>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Lymphocyte T</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>T-Lymphocyte</s0>
<s5>11</s5>
<s6>«T»-Lymphocyte</s6>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Linfocito T</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Immunodépresseur</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Immunosuppressive agent</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Inmunodepresor</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Interaction moléculaire</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Molecular interaction</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Interacción molecular</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Maladie autoimmune</s0>
<s5>16</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Autoimmune disease</s0>
<s5>16</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Enfermedad autoinmune</s0>
<s5>16</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Activité biologique</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Biological activity</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Actividad biológica</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Article synthèse</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Review</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Artículo síntesis</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Activation</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Activation</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Activación</s0>
<s5>19</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Analyse structurale</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Structural analysis</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Análisis estructural</s0>
<s5>20</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Structure 3 dimensions</s0>
<s5>21</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Three dimensional structure</s0>
<s5>21</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Estructura 3 dimensiones</s0>
<s5>21</s5>
</fC03>
<fN21><s1>263</s1>
</fN21>
</pA>
</standard>
</inist>
<affiliations><list><country><li>Australie</li>
<li>États-Unis</li>
</country>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Kem, W R" sort="Kem, W R" uniqKey="Kem W" first="W. R." last="Kem">W. R. Kem</name>
</noRegion>
<name sortKey="Pennington, M W" sort="Pennington, M W" uniqKey="Pennington M" first="M. W." last="Pennington">M. W. Pennington</name>
</country>
<country name="Australie"><noRegion><name sortKey="Norton, R S" sort="Norton, R S" uniqKey="Norton R" first="R. S." last="Norton">R. S. Norton</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005F12 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 005F12 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PascalFrancis |étape= Checkpoint |type= RBID |clé= Pascal:99-0408262 |texte= Sea anemone toxins as templates for the design of immunosuppressant drugs }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |